You are on page 1of 8

SOFT TISSUE SARCOMAS

• AETIOLOGY : UNKNOWN
• High-risk factor :
- Neurofibromatosis ( Von
Recklinghausen`s disease)
- Previous radiation therapy
- Long-lasting lymphoedema
Pathological appearance
• Originate from all mesenchymal tissues ( fat, muscular, connective
tissue, vessels, peripheral nerves, tendon and synovial

• Benign tumor(- omas), malignant tumor (- sarcomas)


- Connective tissue : fibroma- fibrosarcoma
- Fat tissue : lipoma – liposarcoma
- Striated muscle : rhabdomyoma- rhabdomyosarcoma
- Smooth muscle : leiomyoma- leiomyosarcoma
- Blood vessel : haemangioma-haemangiosarcoma
- Lymph vessel : lymphangioma-lymphangIosarcoma

Grade of malignancy : grade I,II,III,IV ( well-moderate, poorly and


undifferentiated)
Biological behaviour
• Benign soft tissue tumour grow non-invasive but
expansive, do not metastases
• Malignant soft tissue tumour grow expansive
and invasive, frequently metastases
• Expansive growth lead to compression
surrounding tissue and make pseudocapsules
• Sarcoma nearly always spread
hematogeneously,mainly to the lung, only
occasionally to lymphnode (synoviosarcoma,
rhabdomyosarcoma, fibrosarcoma,
angiosarcoma)
Diagnostic approach
Physical examination :
• Inspection : compare the two side
symmetry?, atrophic / contracture muscle,
colour of the skin, functional disorder
• Palpation : skin temperature, swelling
sharply demarcated, ill-defined, size,
fixation to surround tissue, painful,
neurological disorder
Microscopic diagnostics
• Incisional biopsy : standard procedure to
accurate diagnostic
• FNAB : not establish and not standard,
indication for tumour recurrent, tumour
metastases
• Immuno-histochemistry : golden standard
to mention accurate diagnostic
Staging tumour
According to TNM-G system

T 1 : tumour < 5 cm, T1a : superficial tum or


T1b : deep tumor
T 2 : tumour > 5 cm, T2a and T2b ( superficial and deep)

No : no regional metastases
N1 : positive regional lymphnode metastases

M0 : No distant metastases
M1 : Positive distant metastases

G1,2,3,4 (well,moderate,poorly,undiffer)

Stage 1A : G1-2, T1a or T1b ,N0,M0 ( low grade, small, superficial ,deep)
Stage IB : G 1-2, T2a , No,MO (low grade, large,superficial,
Stage IIA : G!-2, T2b, No,MO ( low grade,large,deep
Stage IIB : G3-4, T1-b,NO,MO ( high grade,small superf, or deep)
Stage IIC : G3-4, T2a, No,MO ( high grade, large, superficial tumor
Stage III : G3-4, T2b, No,Mo ( high grade, large, deep tumor)
Stage IV : any G,Any T,No,Ni,Mo,Mi (any meta lymphnode,distant metastases)
Treatment of STS
• Local treatment : standart therapy
- Wide excision ( compartment procedure,
amputation, safety margin 2 cm )
-Radiotherapy
• Systemic treatment : adjuvant therapy
Chemotherapy adjuvant (cyclophosphamide,
ifosphamid, adriamycin, dacarbacin,
vincristin, taxane, Growth factor /VEGF
Prognosis of STS

• Prognostic factors :
- Type of tumor
- Grade of malignancy
- Size of tumor
- Location
- Metastases
- Age of patient
- Recurrence

You might also like